期刊文献+

妥布霉素结晶过程中影响因素的研究及参数优化 被引量:4

Research on influential factors and optimizationin the process of cry stallization of tobramycin
下载PDF
导出
摘要 本文通过正交分析,以最终收率和效价为指标对妥布霉素结晶过程中的影响因素如:乙醇添加量、温度、时间、搅拌速度等进行了研究并对其优化,得出了不同情况下的最佳参数组合:当考虑收率时,采用A3B2C3D2组合即:结晶液:乙醇为1: 12;结晶温度为25°C,结晶时间为14h,搅拌速度为200r/min。当考虑效价时,最佳影响因素组合A2B3C1D2,即:结晶液:乙醇为1:10;结晶温度为35℃,结晶时间为10h,搅拌速度为200r/min。综合平衡后可用作为实际生产的最佳影响因素组合,结晶液:乙醇1:12,结晶温度25℃,结晶时间10h,搅拌速度300r/min。 ABSTRACT:In this paper, the effective factors such as ethanol addition volume, temperature, time and stirringrate and so on in the process of crystallization of tobramycin with the final yield and titer as indices was analysed byorthogonal method. At the same time, the optimal reference combination under different conditions was obtained. Whenthe final yield was put in the first place, the optimal condition was as follows: crystallization solution: ethanol = 1: 12,temperature 25°C, time 14h and stirring rate 200r/min; When the titer was considered in the first place, the optimalreference combination was as follows: crystallization solution: ethanol = 1: 10, temperature 35°C, time 10h and stirring rate200r/min. Considering comprehensively, the optimal condition was as follows: crystallization solution: ethanol = 1: 12, temperatuer 25°C,time 10h and stirring rate 300r/min.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2002年第4期221-223,共3页 Chinese Journal of Antibiotics
基金 广东省自然科学基金资助项目 项目编号:980547
关键词 妥布霉素 结晶 影响因素 抗生素 正交 实验 温度 时间 搅拌速度 KEYWORDS:Tobramycin Crystallization Effective factors
  • 相关文献

参考文献5

  • 1LiuST.Tobramycin [J].抗生素,1987,8:346-346.
  • 2Zhang S W. A discuss about separation and purification inantibiotic production [J]. Pharma Ind( 医药工业 ), 1988; 19(3) :139
  • 3Lan G Z. Application of multifactors on crystallization oftobramycin [J]. Channal Pharmaceutics ( 海峡药学 ), 1995 ;7(1):17
  • 4National Commmittee of Pharmacopoeia of People's Republicof China. (中华人民共和国卫生部药典)[S]. 2000 ed.Beijing: Chemical Industry Publishing House, 2000: 312
  • 5United States Pharmacopeial Convention Inc. The UnitedStates Pharmacoreia X X Ⅳ [S]. Taunton: Rand McNall12000:1558

同被引文献25

  • 1顾慧儿,陶珍,许先栋,赵淑敏,吴香玫.克林霉素磷酸酯的理化性质及稳定性研究[J].中国医药工业杂志,1994,25(10):451-454. 被引量:7
  • 2侯杰,刘健,盛惊州,李家泰.国产克林霉素磷酸酯体外抗菌作用研究[J].中国抗生素杂志,1996,21(2):124-132. 被引量:20
  • 3赵茜,高大维,秦贯丰.盐酸林可霉素晶种制备新工艺研究[J].中国抗生素杂志,1997,22(2):87-89. 被引量:4
  • 4The Pharmacopeia of the United States of America, Twenty-Fourth Revision (USP24)[M]. 2000: 432-433.
  • 5王靖康.化学工程手册-结晶[M].第2版.北京:化学工业出版社,1996:4-5.
  • 6Chen Y, Wang J K. Solubility of clindamycin phosphate in binary water-ethanol solvent [J]. Chem. Eng. Data., 2007, 52.:1908-1910.
  • 7丁绪淮,谈遒.工业结晶(第一版)[M].北京:化学工业出版社,1995:139.
  • 8谢智 常志东 孙兴华 等.Avermectin溶解度的测定与关联.中国抗生素杂志,.
  • 9Shoop W L, Mrozik H. Fisher M H. Structure and activity of avermectins and milbemycins in animal health [J].Vet Parasitol , 1995,59 : 139.
  • 10Mckellar Q A, Benchaoui H A. Avermectins and milbermycins [J]. J Vet Pharm Ther, 1996.19:331.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部